Search results
1 paź 2021 · Patients with Covid-19 place new challenges on the management of type 2 diabetes, including the questions of whether glucose-lowering therapy should be adjusted during infection and how to manage a return to normal care after resolution of Covid-19 symptoms.
13 lis 2020 · During the COVID-19 pandemic, tight control of glucose levels and prevention of diabetes complications might be crucial in patients with diabetes mellitus to keep susceptibility low...
4 gru 2021 · Therefore, many health agencies have recommended avoiding sodium–glucose co-transporter 2 (SGLT2) inhibitors in COVID-19 patients and patients with a history of hypertension, type 2 diabetes mellitus (T2DM), and atherosclerotic cardiovascular disease such as heart failure . Besides, treatment with glucagon-like peptide-1 receptor agonists ...
25 lis 2022 · This review covers the most recent developments in DM and COVID-19 and shifts the primary emphasis to treatment advice for DM patients at risk for or with COVID-19-related illnesses. Most existing research does not differentiate between different types of diabetes and is mostly focused on T2DM due to its high prevalence [ 8 ].
8 sie 2024 · Treatment strategies. Insulin therapy is the preferred treatment for COVID-19 patients with severe hyperglycemia, especially for heavy and critically ill patients. Insulin therapy exerts a powerful anti-inflammatory effect during critical illness and improves blood glucose management in hospitalized patients [41].
4 paź 2021 · It is important to differentiate between ongoing diabetes treatment and treatment of hyperglycaemia arising during acute SARS-CoV-2 infection.
23 kwi 2020 · Given the importance of the link between COVID-19 and diabetes, we have formed an international panel of experts in the field of diabetes and endocrinology to provide some guidance and practical recommendations for the management of diabetes during the pandemic.
